Clinical Trials Directory

Trials / Completed

CompletedNCT00357019

Study of the Clinical and Biological Efficacity of NAAXIA SINE® in Vernal Keratoconjunctivitis

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
Sponsor
Laboratoires Thea · Industry
Sex
All
Age
4 Years
Healthy volunteers
Not accepted

Summary

To assess the clinical and biological efficacity of preservative free NAAGA eyes drops in vernal keratoconjunctivitis

Detailed description

The objective of this pilot study is to evaluate the clinical and biological efficacy of preservative free NAAGA eyedrops in VKC -by in particular the levels of ECP and MPO in tears- comparatively to the activity of levocabastine eyedrops.

Conditions

Interventions

TypeNameDescription
DRUGN-acetyl-aspartyl-glutamate (NAAXIA Sine)

Timeline

Start date
2001-04-01
Completion
2002-10-01
First posted
2006-07-27
Last updated
2006-07-27

Source: ClinicalTrials.gov record NCT00357019. Inclusion in this directory is not an endorsement.